4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-051275
Chief Financial Officer sold 15,000 shares at an average $34.07 ($511,049)
- Chief Financial Officer acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Cohen Chad M · Chief Financial Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-10 | Exercise or conversion : show line 1 in the form | +5,000 | $6.55 | $32,750 | 26,604 | D |
| 2021-08-10 | Sale : show line 2 in the form | −5,000 | $35.00 | $175,000 | 21,604 | D |
| 2021-08-11 | Exercise or conversion : show line 3 in the form | +10,000 | $6.55 | $65,500 | 31,604 | D |
| 2021-08-11 | Sale : show line 4 in the form | −8,738 | $33.48 | $292,548 | 22,866 | D |
| 2021-08-11 | Sale : show line 5 in the form | −1,262 | $34.47 | $43,501 | 21,604 | D |
| Open-market sales · 15,000 sh · avg $34.07 · $511,049 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-08-10 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −5,000 | 85,000 | D |
| 2021-08-11 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −10,000 | 75,000 | D |
Loading xslF345X03/doc4.xml…